Breaking News
Sort by:
Top Post
UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and UNICEF today announced […]
Samsung Biologics to Add mRNA Vaccine Drug Substance Manufacturing Suite to Expand Portfolio of Services
Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing end-to-end contract development and manufacturing services, […]
Janssen single dose Covid-19 vaccine authorised by UK medicines regulator
Janssen’s single-dose COVID-19 vaccine has been authorised for use by the UK medicines regulator. The […]
Novartis and Molecular Partners Announce Start of EMPATHY Clinical Trial for Ensovibep for the Treatment of COVID-19
Novartis and Molecular Partners announced today the start of the clinical trial EMPATHY, a Phase […]
Moderna Announces TeenCOVE Study of COVID-19 Vaccine (mRNA-1273) in Adolescents Meets Primary Endpoint
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Study into Whether Vaccination of Previously Infected Generates Stronger, Broader Coronavirus Antibody Response
NHS Blood and Transplant (NHSBT) is carrying out a study in the Birmingham region aimed […]
Vaccine Status Drives Over One Million New Users to the NHS App
Over 1.3 million new people have registered to use the NHS App since the addition […]
Pfizer Initiates Study Exploring Coadministration of 20vPnC Vaccine Candidate
Pfizer Inc. (NYSE: PFE) today announced that the first enrolled subjects have received their immunizations as […]
Moderna and Aldevron Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline
Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the […]
60 Million Doses of Covid-19 Vaccine Administered in UK
Around 72% of UK adults have received a first dose of a COVID-19 vaccine, the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more